Opening book details…
Can I read Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature on EtoBox?
Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature by Sandra Zingg; G Jacopo Nicoletti; Sabine Kuster; Milena Junker; Andreas Widmer; Adrian Egli; Vladimira Hinic; Parham Sendi; Manuel Battegay; Veronika Bättig; Nina Khanna; Sarah Tschudin-Sutter is a Medicine article available to read on EtoBox.
What is Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature about?
## Abstract Cefiderocol is a new siderophore cephalosporin with activity against carbapenem-resistant gram-negative bacteria. Data on its clinical efficacy are limited to complicated urinary tract infections. We present a series of 3 patients successfully treated with cefiderocol for complicated health care–associated infections and review published case reports.
Who reads Cefiderocol for Extensively Drug-Resistant Gram-Negative Bacterial Infections: Real-world Experience From a Case Series and Review of the Literature?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Sandra Zingg; G Jacopo Nicoletti; Sabine Kuster; Milena Junker; Andreas Widmer; Adrian Egli; Vladimira Hinic; Parham Sendi; Manuel Battegay; Veronika Bättig; Nina Khanna; Sarah Tschudin-Sutter
- Publisher
- Oxford University Press (OUP)
- Published
- 2020
- Language
- EN
- Field
- Medicine (Health Sciences)